SEATTLE, May 05, 2020 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global meperidine (Demerol) market is estimated to be valued at US$ 2,089.1 Mn in 2020, and is expected to exhibit a CAGR of 4.2% during the forecast period (2020-2027).
Key Trends and Analysis of the Global Meperidine (Demerol) Market:
Meperidine (Demerol) is used as a pain reliever in post-operative pain management, which is expected to support growth of the injectable meperidine. This is also expected to increase demand for meperidine injection sold through hospital pharmacies as it would be sold in the hospitals through this channel. Manufacturers such as Hikma Pharmaceuticals offer injectable forms of the opioid meperidine.
Request for Sample PDF copy @ https://www.coherentmarketinsights.com/insight/request-sample/3816
Moreover, meperidine offers advantages over other opioids such as lesser risk of addiction, and safer than morphine. Due to its short duration of action and limited analgesia or anesthetic effect, it may be effective as an opioid of choice for minimally invasive surgeries.
Moreover, in 2015, Validus Pharmaceuticals LLC (Validus), together with Wood Creek Capital Management, LLC acquired U.S. rights to product lines from Sanofi US which include Demerol (meperidine hydrochloride) tablets. Presence of generic versions of the drug in the market have supported the growth of the segment over the past few years. Manufacturers such as Teva Pharmaceuticals, Hikma Pharmaceuticals, and others offer generic meperidine in the market. Generic meperidine is pharmacologically equivalent to Demerol, and is cost effective than brand Demerol as well.
Apart from this, reimbursement offered by private insurance companies as well as government insurance (Medicare) has supported growth of the U.S. market. For instance, spending on meperidine through Medicare is on the rise for the past few years according to Medicare Part D spending data. These factors are expected to support the North America meperidine (Demerol) market growth during the forecast period.
Read Report Summary @ https://www.coherentmarketinsights.com/market-insight/meperidine-market-3816
Global meperidine (Demerol) Market: Restraints
The major factor restraining the market growth is the presence of alternative potent opioid medications, and risk of side effects such as accumulation of the toxic metabolite normeperidine and possible generalized seizures associated with meperidine.
Key Market Takeaways:
- The market is expected to exhibit a CAGR of 4.2% during the forecast period (2020-2027). This growth is attributed to the increasing number of surgeries, approvals of meperidine (Demerol) products, and the rising demand for opioid medications in pain management.
- Injectable meperidine is expected to witness significant growth during the forecast period owing to the increasing use of the drug in managing post-operative pain.
Key players operating in the global meperidine (Demerol) market are—
- Pfizer, Inc.,
- Hikma Pharmaceuticals USA Inc.,
- Epic Pharma, Inc.,
- Teva Pharmaceutical Industries Ltd.,
- Vintage Pharmaceuticals, Inc.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3816
Market Segmentation:
- Global Meperidine (Demerol) Market, By Dosage Form:
- Tablet
- Injection
- Syrup
- Global Meperidine (Demerol) Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Meperidine (Demerol) Market, By Region:
- North America
-
- U.S.
- Canada
- Europe
-
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Latin America
-
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Asia Pacific
-
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
-
- GCC
- Israel
- Rest of Middle East
- Africa
-
- Central Africa
- South Africa
- North Africa
Related Topics:
EYE HEALTH SUPPLEMENTS MARKET
Eye health supplements are pharmaceutical preparations used in maintaining eye health. Antioxidants such as Lutein and Zeaxanthin of the carotenoid family are some of the eye health ingredients. Use of antioxidants as eye health ingredients is expected to grow steadily over the forecast period. Increase in number of eye health supplements is also projected to enhance the growth of eye health ingredients market during the forecast period.
Read more @ https://www.coherentmarketinsights.com/market-insight/eye-health-supplements-market-3791
HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET
Healthcare Contract Research Outsourcing is conducted by pharmaceutical and medical device sectors for development of new drugs and medical devices. Clinical trials form the key part of pharmaceutical drug and medical device development and in the current scenario clinical trials are conducted across multiple locations in various geographies.
Read more @ https://www.coherentmarketinsights.com/market-insight/healthcare-contract-research-outsourcing-market-3788